StockWatch
·
Biotechnology: Pharmaceutical Preparations
Board MeetingMay 1, 2026, 07:31 AM

IFRX to Announce Q1 2026 Results on May 7

AI Summary

InflaRx N.V. (IFRX) announced it will publish its financial and operating results for the first quarter 2026 on May 7, 2026, before the market opens. The biopharmaceutical company, focused on anti-inflammatory therapeutics, also stated that no conference call is planned for this announcement.

Key Highlights

  • IFRX to publish Q1 2026 financial and operating results on May 7, 2026.
  • Results will be released before the market opens.
  • No conference call is planned for the Q1 2026 results.